Dopamine D2 receptor activator quinpirole protects against trypsinogen activation during acute pancreatitis via upregulating HSP70
| Autor: | Xiao Han, Guoyong Hu, Juan-juan Dai, Yan He, Bin Li, Li Wen, Xin Ye, Zengkai Wu |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Agonist
Quinpirole Physiology medicine.drug_class HSP72 Heat-Shock Proteins Pharmacology Cathepsin B Mice Downregulation and upregulation Heat Shock Transcription Factors Physiology (medical) Dopamine receptor D2 medicine Animals Protein Phosphatase 2 Trypsinogen activation Phosphorylation Pancreas Hepatology Chemistry Receptors Dopamine D2 Gastroenterology medicine.disease Up-Regulation Mice Inbred C57BL Gene Expression Regulation Pancreatitis Dopamine Agonists Trypsinogen Acute pancreatitis Lysosomes Ceruletide medicine.drug |
| Zdroj: | American journal of physiology. Gastrointestinal and liver physiology. 318(6) |
| ISSN: | 1522-1547 |
| Popis: | Trypsinogen activation is the hallmark of acute pancreatitis (AP) independent of intra-acinar NF-κB activation and inflammation. We previously found that dopamine (DA) receptor 2 (DRD2) activation controls inflammation during AP via PP2A-dependent NF-κB activation. In this study, we sought to examine whether DRD2 signaling mediates trypsinogen activation and the underlying mechanisms. Pancreatic acinar cells were stimulated with cholecystokinin-8 in vitro. AP was induced by intraperitoneal injections of caerulein and LPS or l-arginine. Pancreatitis severity was assessed biochemically and histologically. We found that activation of DRD2 by quinpirole, a potent DRD2 agonist, resulted in the reduction of trypsinogen activation and the upregulation of HSP70 in vitro and in vivo. Mechanistically, we found that quinpirole induced dephosphorylation of heat shock factor 1 (HSF1), a master transcription factor of HSP70, leading to increased nuclear translocation of HSF1 in a PP2A-dependent pathway. Furthermore, DRD2 activation restored lysosomal pH and, therefore, maintained lysosomal cathepsin B activity in a HSP70-dependent manner. VER155008, a potent HSP70 antagonist, abolished the protective effects observed with DRD2 activation in vitro and in two experimental models of AP. Our data showed that besides controlling NF-κB activation, DRD2 activation prevented trypsinogen activation during acute pancreatitis via PP2A-dependent upregulation of HSP70 and further support that DRD2 agonist could be a promising therapeutic strategy for treating AP.NEW & NOTEWORTHY The current study demonstrated that activation of DRD2 by quinpirole protects against trypsinogen activation in the in vitro and in vivo setting of acute pancreatitis by upregulating HSP70 and restoring lysosomal degradation via a PP2A-dependent manner, therefore leading to reduced pancreatic injury. These findings provide a new mechanistic insight on the protective effect of DRD2 activation in acute pancreatitis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|